Interventional MR Study Group

Tuesday, 4 May 2010
18:15 to 20:15
Room A5

This symposium has two principal aims: (1) to provide guidance for new or inexperienced sites on how to establish an effective IMR program and (2) to address controversies in the field. We will specifically tackle what the ideal field strength is for iMRI sites and openly discuss the necessity of real time MR guidance versus efficient use of previously acquired or iterative intra-procedure MR data. This discussion will focus on cardiac EP ablations.
18:15 Administrative Business
18:30 Running an iMRI program: How We Do It (15-minutes presentations)
Thermal – R. Jason Stafford, Ph.D., University of Texas M.D. Anderson Cancer Center, Houston, TX, USA
Neuro – Charles L. Truwit, M.D., University of Minnesota, Minneapolis, MN, USA
19:00 Controversies in iMRI – Optimal Field Strength for IMR
(3 10-minute “position statements”, 15 min panel discussion)
1T AdvocateUlf Teichgräber, M.D., Charité - Universitätsmedizin Berlin, Berlin, Germany
1.5T Advocate – Clifford R. Weiss, M.D., Johns Hopkins University, Baltimore, MD, USA
3T AdvocateClare Tempany, M.D., /Kemal Tuncali, Brigham and Women’s Hospital, Boston, MA, USA
19:45 Controversies in iMRI – MR Guided versus MR Assisted for Cardiac EP
(2 10-minute “position statements”, 10 min panel discussion)
MR Guided AdvocateGraham A. Wright, Ph.D.,  University of Toronto, Toronto, ON, Canada
MR Assisted AdvocateTobias R. Schaeffter, Ph.D., Kings College London, London, UK
20:15 Adjourn

Back to Main Meeting

Back to Home